Related references
Note: Only part of the references are listed.Simultaneous Emergence of Entecavir Resistance Mutations in a Nucleoside-Naive Chronic Hepatitis B Patient
Hyun Woong Lee et al.
INTERVIROLOGY (2012)
Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients
Atsushi Ono et al.
JOURNAL OF HEPATOLOGY (2012)
Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication
Hidehiro Kamezaki et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naive patient
Jin-Jun Guo et al.
ANTIVIRAL RESEARCH (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response
Carl J. Baldick et al.
JOURNAL OF HEPATOLOGY (2008)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H
Fumitaka Suzuki et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir
M Hussain et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
CL Lai et al.
CLINICAL INFECTIOUS DISEASES (2003)
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: Evaluation of performance of INNO-LiPA HBV DR assay
ASF Lok et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
